Difference between revisions of "Team:Marburg/Design"

Line 229: Line 229:
 
                       features of these CRISPR/Cas systems, but how to actually apply it differs:<br>
 
                       features of these CRISPR/Cas systems, but how to actually apply it differs:<br>
 
                       For Cas9 each sgRNA is in need of its own promoter, which means that they have to be expressed
 
                       For Cas9 each sgRNA is in need of its own promoter, which means that they have to be expressed
                       from different vectors or a multi cassette vector (
+
                       from different vectors or a multi cassette vector (<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0058">Swarts & Jinek, 2018</a>;
                      <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0058">X. Ma <i>et
+
                        al.</i>, 2015</a>;
+
 
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0104"> Z. Zhang
 
                       <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0104"> Z. Zhang
                         <i>et al.</i>, 2016 </a> ). In contrary, multiplexed genome editing with Cas12a can be achieved simply
+
                         <i>et al.</i>, 2016</a>). In contrary, multiplexed genome editing with Cas12a can be achieved simply
 
                       by expressing all of the needed guide RNAs in one transcriptional unit, the crRNA.
 
                       by expressing all of the needed guide RNAs in one transcriptional unit, the crRNA.
                      <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/wrna.1481#wrna1481-bib-0065">(Kim, et
+
                      This is a huge advantage of Cas12a. Furthermore,
                        al., 2016; Nishimasu <i>et al.</i>, 2017)</a>. This is a huge advantage of Cas12a. Furthermore,
+
 
                       CRISPR/Cas9 was shown to be toxic in cyanobacteria
 
                       CRISPR/Cas9 was shown to be toxic in cyanobacteria
 
                       <a href="https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0514-7">
 
                       <a href="https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0514-7">
Line 254: Line 251:
 
                       used for lvl 1 assembly were: pMC0_1_03 + pMC0_2_03 + pMC0_3_07 + pMC0_4_33 + pMC0_5_07 +
 
                       used for lvl 1 assembly were: pMC0_1_03 + pMC0_2_03 + pMC0_3_07 + pMC0_4_33 + pMC0_5_07 +
 
                       pMC0_6_17. For the construction of the crRNA part the design of the plasmid pSL2680 was mainly
 
                       pMC0_6_17. For the construction of the crRNA part the design of the plasmid pSL2680 was mainly
                       maintained, but the <i>lacZ</i> cassette was replaced by a GFP cassette to enable easier screening
+
                       maintained, but the <i>lacZ</i> cassette was replaced by a GFP cassette with BsmBI cutting sites to enable easier screening
                       of crRNA assembly and to reduce expenses for X-Gal/IPTG. It was constructed as a part reaching
+
                       of gRNA assembly and to reduce expenses for X-Gal/IPTG. It was constructed as a part reaching
 
                       from the RBS site to the end of the terminator site. As the whole system is built for modular
 
                       from the RBS site to the end of the terminator site. As the whole system is built for modular
 
                       cloning in PhytoBrick syntax, it is possible to freely exchange the parts around the Cas12a and
 
                       cloning in PhytoBrick syntax, it is possible to freely exchange the parts around the Cas12a and

Revision as of 16:04, 8 December 2019

D E S I G N



"Always plan ahead. It wasn’t raining when Noah build the ark." - Richard Cushing


What does expanding the Golden Gate based Marburg Collection, automating time consuming lab work and establishing the CRISPR/Cas12a system in Synechococcus elongatus UTEX 2973 have in common?
To achieve these objectives, it is always necessary to have a comprehensive theoretical preparation. It all starts with literature research, summarizing the current state of the art and based on this developing own ideas. To have the theoretical background settled, before the lab work starts, is a key point of every project and consumes many hours.
Because in the near future phototrophic organisms will be more and more relevant for biotechnological applications, we want to establish the use of Synechococcus elongatus as a phototrophic organism for Synthetic Biology. Following the principles of Synthetic Biology to simplify the process of engineering of biological systems, we set it our goal to establish Synechococcus elongatus UTEX 2973 as the fastest and most accessible phototrophic chassis to date, providing it as a wind tunnel for phototrophic organisms with user friendly and standardized workflows.
In order to achieve these goals, a lot of effort has been put into designing, building, testing, evaluating and learning. Further, these steps had to be iterated over and over again to elaborate our standardized designs. By providing you our theoretical background we want to give you an insight in our decision-making.


S T R A I N
E N G I N E E R I N G


We modified Synechococcus elongatus UTEX 2973 to establish the CRISPR/Cas12a system in our organism.

T O O L B O X


We expanded last years Marburg Collection and made the parts suitable for Synechococcus elongatus UTEX 2973.